# Assessing Serum Neurofilament Light Chain in Hereditary Transthyretin Amyloidosis: Direct Comparison of Three Immunoassays

**Authors:** Milou Berends, Johan Bijzet, Suzanne Arends, Elisabeth Brouwer, Charlotte E. Teunissen, Sjors G. J. G. in ’t Veld, Reinold O. B. Gans, Bouke P. C. Hazenberg, Paul A. van der Zwaag, Hans L. A. Nienhuis, Bart-Jan Kroesen

PMC · DOI: 10.3390/jcm15041584 · Journal of Clinical Medicine · 2026-02-18

## TL;DR

This study compares three methods for measuring a biomarker in a genetic disease and finds they are comparable, though with slight differences.

## Contribution

The study directly compares three immunoassays for serum neurofilament light chain in hereditary transthyretin amyloidosis, showing their suitability as alternatives.

## Key findings

- Median sNfL levels varied significantly across the three assays.
- Strong correlations were observed between the assays with very high correlation coefficients.
- Z-score normalization enabled inter-assay comparisons despite concentration differences.

## Abstract

Background/Objectives: Serum neurofilament light chain (sNfL) is an early and sensitive biomarker of polyneuropathy. This study compared the UmanDiagnostics enzyme-linked immunosorbent assay (ELISA), and Meso Scale Discovery (MSD) R-PLEX assay with the current gold-standard single-molecule array (Simoa) assay for sNfL measurement. Methods: sNfL levels were measured with Simoa, ELISA, and MSD R-PLEX in 330 serum samples from 73 individuals with a pathogenic transthyretin gene variant (TTRv) and in 165 healthy controls (HC) with ELISA and MSD R-PLEX. Results: Median sNfL levels, assessed in serum samples from TTRv individuals, differed across all assays (all p < 0.001). Passing–Bablok regression slopes were 1.01 (Simoa–ELISA), 1.00 (Simoa–MSD R-PLEX), and 1.02 (MSD R-PLEX-ELISA), with very strong correlations (all r > 0.8). Bland–Altman analysis showed mean differences of 0.1 ± 0.2 pg/mL (Simoa–ELISA), 0.7 ± 0.1 pg/mL (Simoa–MSD R-PLEX), and −0.6 ± 0.2 pg/mL (MSD R-PLEX-ELISA). In HC, sNfL levels positively correlated with age. Z-score normalization allowed for inter-assay comparison. Conclusions: The ELISA and MSD R-PLEX assays provide suitable alternatives for the Simoa assay to measure sNfL levels in carriers of a pathogenic TTR-gene variant. The differences in concentrations defined by the assays directly relate to the internal standard provided with the assays.

## Linked entities

- **Genes:** TTR (transthyretin) [NCBI Gene 7276]
- **Diseases:** polyneuropathy (MONDO:0001824)

## Full-text entities

- **Genes:** NEFL (neurofilament light chain) [NCBI Gene 4747] {aka CMT1F, CMT2E, CMTDIG, NF-L, NF68, NFL}, PSIP1 (PC4 and SRSF1 interacting protein 1) [NCBI Gene 11168] {aka DFS70, LEDGF, PAIP, PSIP2, p52, p75}, NEFL (neurofilament light chain) [NCBI Gene 281348], TPPP (tubulin polymerization promoting protein) [NCBI Gene 11076] {aka TPPP/p25, TPPP1, p24, p25, p25alpha}, TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}
- **Diseases:** ATTRv amyloidosis (MESH:D000686), Dementia (MESH:D003704), Amyloid (MESH:C000718787), peripheral and autonomic neuropathy (MESH:D010523), Multiple Sclerosis (MESH:D009103), Axonal nerve damage (MESH:D001480), cognitive disturbances (MESH:D003072), Hereditary Transthyretin Amyloidosis (MESH:C567782), injury to (MESH:D014947), HC (MESH:D000067329), polyneuropathy (MESH:D011115), Alzheimer (MESH:D000544), Neuroinflammation (MESH:D000090862)
- **Chemicals:** SULFO-TAG (-)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.Val50Met

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942544/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942544/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942544/full.md

---
Source: https://tomesphere.com/paper/PMC12942544